NOVEL JNP3 COMPOUND ISOLATED FROM TRADITIONAL CHINESE MEDICINE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR ANTI-CANCER

• 1. 包含含有大量活性成分的从东北婆婆纳中分离的纯化提取物或从此分离的化合物作为用于预防或治疗慢性阻塞性肺病的活性成分的组合物及其用途 [P] . 中国专利： CN105120880B . 2017.06.13
• 2. 包含含有大量活性成分的从东北婆婆纳中分离的纯化提取物或从此分离的化合物作为用于预防或治疗慢性阻塞性肺病的活性成分的组合物及其用途 [P] . 中国专利： CN105120880A . 2015-12-02
• 3. A new compound JNP3 isolated from traditional Chinese medicine and pharmaceutical composition for anti-cancer containing the same as effective ingredient [P] . 韩国专利： KR101484526B1 . 2015-01-21

  机译： 从中药中分离得到的新化合物JNP3和含有其作为有效成分的抗癌药物组合物

• 4. A COMPOSITION COMPRISING CHINESE TRADITIONAL MEDICINE AS ACTIVE INGREDIENT FOR TREATING CARDIOVASCULAR DISEASES AND QUALITY CONTROL METHOD THEREOF [P] . 世界知识产权组织专利： WO2008064592A1 . 2008-06-05

  机译： 一种中药为治疗心血管疾病的有效成分的组合物及其质量控制方法

• 5. Active ingredients preparation and single compound purification from traditional Chinese herbal medicine Fructus Trichosanthis and uses thereof [P] . 美国专利： US7618657B2 . 2009-11-17

  机译： 中草药Tri毛cho活性成分的制备及单一化合物的纯化及其用途

• 1. Structural similarity-based prediction of the potential active ingredients and mechanism of action of traditional Chinese medicine formulations used to anti-aging [J] . Qian Zhang, Shuaibing He, Hongyu Wang, 中医科学杂志（英文） . 2018,第002期
• 2. Structural similarity-based prediction of the potential active ingredients and mechanism of action of traditional Chinese medicine formulations used to anti-aging [J] . Qian Zhang, Shuaibing He, Hongyu Wang, 中医科学杂志(英文) . 2018,第002期
• 3. Impacts of Active Ingredients of Three Traditional Chinese Medicine on Immune Effect of PCV2 Vaccine [J] . Yao Jing, Li Kai, Jiang Chunmao, 动物与饲料科学：英文版 . 2017,第006期
• 4. Potential Preventive and Therapeutic Effects of Traditional Chinese Medicine Compound Prescription and Traditional Chinese Medicine Products on COVID-19 [J] . Wen ZHONG, Haisheng ZENG, Xiumei MA, 药用植物：英文版 . 2021,第003期
• 5. Synthesis, characterization, and in vitro antitumor properties of gold(III) compounds with the traditional Chinese medicine (TCM) active ingredient liriodenine [J] . Chen Zhen-Feng, Liu Yan-Cheng, Peng Yan, Journal of biological inorganic chemistry: JBIC: a publication of the Society of Biological Inorganic Chemistry . 2012,第2期
• 6. Synthesis, characterization, and in vitro antitumor properties of gold(III) compounds with the traditional Chinese medicine (TCM) active ingredient liriodenine [J] . Zhen-Feng Chen, Yan-Cheng Liu, Yan Peng, JBIC Journal of Biological Inorganic Chemistry . 2012,第2期
• 7. Drug-likeness analysis of traditional Chinese medicines: 2. Characterization of scaffold architectures for drug-like compounds, non-drug-like compounds, and natural compounds from traditional Chinese medicines [J] . Sheng Tian, Youyong Li, Junmei Wang, Journal of Cheminformatics . 2013,第S1期
• 8. Determination of active ingredients in several chinese traditional medicines by CE-ED [C] . Yuhua Cao, Changgang Lou, Qingcui Chu, Sino-France Workshop on Surface Electrochemistry of Molecules of Biological Interest and Biosensor Application . 2001
• 9. Profiling of Traditional Chinese Medicine Compound Berberine as Anticancer Agent in Melanoma [D] . Jarboe, Tara Elizabeth. 2019
• 10. Drug-likeness analysis of traditional Chinese medicines: 2. Characterization of scaffold architectures for drug-like compounds non-drug-like compounds and natural compounds from traditional Chinese medicines [O] . Sheng Tian, Youyong Li, Junmei Wang, 2013
• 11. Drug-likeness analysis of traditional Chinese medicines: 2. Characterization of scaffold architectures for drug-like compounds, non-drug-like compounds, and natural compounds from traditional Chinese medicines [O] . Tian Sheng, Li Youyong, Wang Junmei, 2013

• 1. Study on the effective group model of traditional Chinese medicine compound from the perspective of pharmaceutical dynamics [J] . Gao Jie . International Journal of Technology Management . 2017,第005期
• 2. 去甲斑蝥素为前体的新型抗癌化合物及联合用药抗癌研究进展 [C] . 李轶群 ,孙震晓 . 中国环境诱变剂学会风险评价专业委员会第二十届全国学术交流会议 . 2018
• 3. 云南红豆杉枝叶中抗癌活性成分的提取工艺与黄酮类化合物的研究 [A] . 孔繁晟 . 2007